Literature DB >> 7871754

Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element.

M O'Connor1, H U Bernard.   

Abstract

A highly conserved composite regulatory element in the epithelial-specific enhancer of human papillomaviruses (HPVs) consists of an octamer motif separated by exactly 2 bp from a nonpalindromic NFI site. Point mutations within this composite element, created to prevent the binding of Oct-1 or NFI, result in up to 10- to 12-fold decrease in enhancer activity. A mutation preventing the binding of both proteins does not, however, result in any further decrease in activity suggesting a cooperative interaction between these two factors. Electrophoretic mobility shift assays provide evidence that the simultaneous binding of both factors to the composite element is indeed required for efficient activation. Furthermore, evidence demonstrating the inability of Oct-1 by itself to elicit a transcriptional response from this enhancer position suggests that Oct-1 does not activate transcription directly, but rather may play a crucial role in the viral enhancer by tethering NF1 to the composite element. This finding represents both a potentially important mechanism by which HPV gene expression can be regulated and an interesting model for the study of transcriptional cooperativity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7871754     DOI: 10.1006/viro.1995.1053

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.

Authors:  Ellora Sen; Jennifer L Bromberg-White; Craig Meyers
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting.

Authors:  P H Bednarek; B J Lee; S Gandhi; E Lee; B Phillips
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

3.  Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.

Authors:  W Zhao; L T Chow; T R Broker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 4.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

5.  Stimulation of BK virus DNA replication by NFI family transcription factors.

Authors:  Bo Liang; Irina Tikhanovich; Heinz Peter Nasheuer; William R Folk
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

6.  Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification.

Authors:  Kathryn M Spink; Laimonis A Laimins
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1.

Authors:  G J Sibbet; S Cuthill; M S Campo
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Phylogenetic footprinting reveals evolutionarily conserved regions of the gonadotropin-releasing hormone gene that enhance cell-specific expression.

Authors:  Marjory L Givens; Reiko Kurotani; Naama Rave-Harel; Nichol L G Miller; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2004-08-19

9.  Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a.

Authors:  K Yukawa; K Butz; T Yasui; H Kikutani; F Hoppe-Seyler
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  NFI is an essential positive transcription factor for human papillomavirus type 16 early gene expression.

Authors:  Amy Baldwin; Melissa K Hypes; Lucia Pirisi; Kim E Creek
Journal:  Open Virol J       Date:  2007-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.